Medicon Valley is Europe's fastest growing biotech cluster  

Danish-Swedish Medicon Valley is now Europe's 4th largest biotech cluster, says international report

Medicon Valley, a cross-border region straddling both sides of the Øresund bridge linking Denmark and Sweden, is Europe's fastest growing biotech cluster reports Berlingske Tidende Online. According to an international report, Medicon Valley is now the 4th largest in Europe measured on number of drugs under development with UK, Germany and France respectively taking the top three places. And France is only ahead by a fraction. Stuart Henderson, head of the biotech section at Deloitte and Touche comments "When you take into account that the biotech clusters in UK, Germany and France have been established much longer, Medicon Valley shows impressive results with 52 drugs under development."


Medicon Valley's rapid progress has not gone unnoticed in investment circles. Europe's largest investment concern, UK's 3i, is currently considering new investments in Medicon Valley based biotech companies. 3i has already invested in 10 biotech companies in the Nordic region (Scandinavia plus Finland and Iceland) totalling around DKK 240 million (USD 35 million), of which four are located in Medicon Valley.

Next step

Explore business cases

Please contact me

How can we help you?

We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×